Panax notoginseng: Pharmacological Aspects and Toxicological Issues
Nutrients · 02.07.2024 · 16 (13) · 2120
DOI: 10.3390/nu16132120 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 02.07.2024. Verfasst von Cesare Mancuso. Beteiligte Einrichtung: Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo F. Vito 1, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Panax notoginseng, Drugs, Chinese Herbal. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Current evidence suggests a beneficial role of herbal products in free radical-induced diseases. Panax notoginseng (Burk.) F. H. Chen has long occupied a leading position in traditional Chinese medicine because of the ergogenic, nootropic, and antistress activities, although these properties are also acknowledged in the Western world. The goal of this paper is to review the pharmacological and toxicological properties of P. notoginseng and discuss its potential therapeutic effect. A literature search was carried out on Pubmed, Scopus, and the Cochrane Central Register of Controlled Trials databases. The following search terms were used: “notoginseng”, “gut microbiota”, “immune system”, “inflammation”, “cardiovascular system”, “central nervous system”, “metabolism”, “cancer”, and “toxicology”. Only peer-reviewed articles written in English, with the full text available, have been included. Preclinical evidence has unraveled the P. notoginseng pharmacological effects in immune-inflammatory, cardiovascular, central nervous system, metabolic, and neoplastic diseases by acting on several molecular targets. However, few clinical studies have confirmed the therapeutic properties of P. notoginseng, mainly as an adjuvant in the conventional treatment of cardiovascular disorders. Further clinical studies, which both confirm the efficacy of P. notoginseng in free radical-related diseases and delve into its toxicological aspects, are mandatory to broaden its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo F. Vito 1, 00168 Rome, Italy.
- Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.
Zitieren
APA
Mancuso, C. (2024). Panax notoginseng: Pharmacological Aspects and Toxicological Issues. Nutrients, 16(13), 2120. https://doi.org/10.3390/nu16132120
Vancouver
Mancuso C. Panax notoginseng: Pharmacological Aspects and Toxicological Issues. Nutrients. 2024;16(13):2120. doi:10.3390/nu16132120
BibTeX
@article{Mancuso2024,
author = {Mancuso, Cesare},
title = {Panax notoginseng: Pharmacological Aspects and Toxicological Issues},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {13},
pages = {2120},
doi = {10.3390/nu16132120}
}
EUVIMED